Identity
- Security key
- 15155
- Ticker
- FBRX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-06-16
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- FBRX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,573,221,662.54
- Shares outstanding (class)
- 20,478,817
- Shares outstanding (weighted)
- 20,489,993
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 22
- Location
- DALLAS, TX
- Homepage
- https://www.fortebiorx.com
- Description
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.